Accessed 20 Jun 2022 Frias JP, Bonora E, Nevarez Ruiz L et al (2021) Efficacy and safety of dulaglutide 3.0 mg and 4.5 mg versus dulaglutide 1.5 mg in metformin-treated patients with type 2 diabetes in a randomized controlled trial (AWARD-11)
The following individuals participated with the task force at various points throughout the consensus development process: Victoria Gomez, Myron Powell, Eric Likar, Angela F
Shan SJ, Guo Y (2014) Exenatide-induced eosinophilic sclerosing lipogranuloma at the injection site
This article examines the rationale, risks, and alternatives for managing digestive symptoms during GLP-1 therapy
GLP-1 receptors are widely distributed throughout the central nervous system, including brain regions involved in reward processing, motivation, and addictive behaviorsparticularly the mesolimbic dopamine system, which includes the ventral tegmental area and nucleus accumbens